Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.77 |
| ▸ | POLB | P06746 | 1/20 | 0.77 |
| ▸ | GAA | P10253 | 3/20 | 0.61 |
| ▸ | NPC1 | O15118 | 2/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.51 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | GLA | P06280 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.50 |
| ▸ | CASP1 | P29466 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5484360 | 0.89 | MAPT (0.61) | MAPTPOLBGAANPC1MAPK1 | |
| SCHEMBL26738 | 0.87 | MAPT (1.00) | MAPTPOLBGAANPC1MAPK1 | |
| SCHEMBL29979531 | 0.87 | MAPT (1.00) | MAPTPOLBGAANPC1MAPK1 | |
| SCHEMBL8033801 | 0.82 | MAPT (0.72) | MAPTPOLBGAAMAPK1HTT | |
| SCHEMBL1128877 | 0.82 | MAPT (0.62) | MAPTPOLBGAANPC1MAPK1 | |
| SCHEMBL29530940 | 0.81 | MAPT (0.66) | MAPTPOLBGAAMAPK1HTT | |
| SCHEMBL29530480 | 0.81 | MAPT (0.66) | MAPTPOLBGAAMAPK1HTT | |
| SCHEMBL3179244 | 0.81 | MAPT (0.66) | MAPTPOLBGAAMAPK1HTT | |
| SCHEMBL9267999 | 0.81 | MAPT (0.66) | MAPTPOLBGAAMAPK1HTT | |
| SCHEMBL28498875 | 0.81 | MAPT (0.53) | MAPTPOLBGAANPC1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119098205-A | Nitrogen-doped porous carbon-loaded cobalt monoatomic catalyst and preparation method and application thereof | 南京理工大学 | 2024-12-10 | — | — | CN | claimed |
| CN-118667159-A | High-adhesion polyimide positive electrode binder and preparation method and application thereof | 浙江中科玖源新材料有限公司 | 2024-09-20 | — | — | CN | claimed |
| CN-118420915-A | Epoxy group modified polyamide imide binder and preparation method thereof | 浙江中科玖源新材料有限公司 | 2024-08-02 | — | — | CN | claimed |
| CN-117164855-A | High-cohesiveness branched polyimide polymer and preparation method thereof | 江苏环峰电工材料有限公司 | 2023-12-05 | — | — | CN | claimed |
| EP-2613819-B2 | LUBRICIOUS COATINGS FOR MEDICAL DEVICES | BIOINTERACTIONS LTD (GB) | 2020-11-25 | — | — | EP | claimed |
| US-12247040-B2 | Iridium complex compound | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-03-11 | — | — | US | disclosed |
| CN-119504579-A | Method for promoting catalytic synthesis of quinoline derivative by using p-toluenesulfonic acid as ligand and titanocene dichloride | 宁夏师范大学 | 2025-02-25 | — | — | CN | disclosed |
| CN-119098205-A | Nitrogen-doped porous carbon-loaded cobalt monoatomic catalyst and preparation method and application thereof | 南京理工大学 | 2024-12-10 | — | — | CN | disclosed |
| EP-3909963-B1 | IRIDIUM COMPLEX COMPOUND | MITSUBISHI CHEM CORP (JP) | 2024-10-30 | — | — | EP | disclosed |
| CN-118667159-A | High-adhesion polyimide positive electrode binder and preparation method and application thereof | 浙江中科玖源新材料有限公司 | 2024-09-20 | — | — | CN | disclosed |
| CN-118420915-A | Epoxy group modified polyamide imide binder and preparation method thereof | 浙江中科玖源新材料有限公司 | 2024-08-02 | — | — | CN | disclosed |
| CN-113698308-B | Synthesis method of bromfenac sodium | 山东辰龙药业有限公司 | 2024-06-21 | — | — | CN | disclosed |
| EP-0530994-A1 | Quinazoline derivatives as inhibitors of HIV reverse transcriptase | MERCK & CO. INC. (US) | 1993-03-10 | — | — | EP | disclosed |
| EP-0076017-B1 | PHENYL SUBSTITUTED PYRIDO(1,4)BENZODIAZEPINES AND INTERMEDIATES THEREFOR | A.H. ROBINS COMPANY, INCORPORATED (US) | 1990-08-16 | — | — | EP | disclosed |
| US-4556667-A | (2-((AMINOPYRIDINYL)AMINO)PHENYL)ARYLMETHANONE INTERMEDIATES | A. H. ROBINS COMPANY, INCORPORATED (US) | 1985-12-03 | — | — | US | disclosed |
| US-4519937-A | DOPED UNITS OF A FUSED NITROGEN-CONTAINING UNSATURATED HETEROCYCLIC RING | CHEVRON RESEARCH COMPANY (US) | 1985-05-28 | — | — | US | disclosed |
| US-4519938-A | TRACTABLE, DOPED HETEROCYCLIC RINGS | CHEVRON RESEARCH COMPANY (US) | 1985-05-28 | — | — | US | disclosed |
| US-4495183-A | ANTIULCER AGENTS- GASTROLINTESTINAL DISORDERS | A. H. ROBINS COMPANY, INCORPORATED (US) | 1985-01-22 | — | — | US | disclosed |
| US-4447361-A | ANTIDEPRESSANT | A. H. ROBINS COMPANY, INC. (US) | 1984-05-08 | — | — | US | disclosed |
| EP-0076017-A2 | Phenyl substituted pyrido(1,4)benzodiazepines and intermediates therefor | A.H. ROBINS COMPANY, INCORPORATED (US) | 1983-04-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12247040-B2 | Iridium complex compound | IPO5, CXCR5, PRMT5 | MAPT 3004/4885POLB 2660/4885GAA 4636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.